Oncology Corporate Profile
Advantagene is a Boston-area privately held biopharmaceutical company focused on preventing the recurrence and progression of cancer through the use of novel therapeutics in oncology and immunotherapy that improve current care. Founded in 1999, the company's experience and expertise has continuously progressed, providing a strong foundation for its work developing, manufacturing and testing gene-based biologics at the forefront of biomedical research. Advantagene strives to address areas of unmet medical need while maintaining lower long-term costs for patients. The company is developing and testing possible cancer treatment products with breakaway potential.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|GMCI||immunotherapy||Non Small Cell Lung Cancer (NSCLC)||I|
View additional information on product candidates here »